NL8701226A - Imidazochinolinyletherderivaten met geneesmiddelwerking, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten die deze derivaten bevatten. - Google Patents
Imidazochinolinyletherderivaten met geneesmiddelwerking, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten die deze derivaten bevatten. Download PDFInfo
- Publication number
- NL8701226A NL8701226A NL8701226A NL8701226A NL8701226A NL 8701226 A NL8701226 A NL 8701226A NL 8701226 A NL8701226 A NL 8701226A NL 8701226 A NL8701226 A NL 8701226A NL 8701226 A NL8701226 A NL 8701226A
- Authority
- NL
- Netherlands
- Prior art keywords
- formula
- aromatic
- methyl
- ortho
- oxo
- Prior art date
Links
- 0 CC(NC1(C2C1)C(N)=NC(C=C*1*)=C2C=C*1O**)=O Chemical compound CC(NC1(C2C1)C(N)=NC(C=C*1*)=C2C=C*1O**)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (111)
1 X / r^V·’VI \ ' | 0 °*3 V^L-Q w-jjO ®3 3 . Λ λ , , - <r- -. - ^ - . -_ * * ' 8701226 * 38 12 Η o ^ H o \ o \ /Ύ CH CH CH CH CN-/ \ ^2 * 'NJ ^ · £)
39 L3 ΠΓνΥ> q^vvo \ o r^\ \ /^N CH2CH2CH2CH2CN-™2 . ° CH2CH3 40 h * (iVy, jfYV>o L 1 Jk ^ 0 \ \ CH2— ch2- N - CH2CH3 ch2-ch2-ch2-oh CH2CH3 Mb t5 a ^*° iOQc \ ° /—\ \ <CH2)4ï-^> “2®2“^®Β 87 0 1 2 2 6 * “. rvvv O Nv \ ^CH—CH—CH, CH.CH-CH.CHCH.' | | * CH„ la OH N— CH^ 3 °H H \TO “3 17 50 X H O v v H 0 \ A. (CH2)3C02Me «2—1-1 ΤΊ-αΟ V" ^3 51 WVv 48 \ " /—^ S (aV3c-f-0 Γ T >- s7 V H 52 "•7—\ ρ= rr'YV· ΥΓ AAA; 0 3 \ ° “ν^νΙΙ-^) ft7 f) 1 9Z% Jf5 ζ y i \&R “K* ... ,,-./.ycrs Cor.u:;,.r·,'' * 53 57 °\ O CH- °v H CH,CH,CH,-S —(. /) \ ii 2 2 2 " \L-y CH CH,CH,OC-CH, O 2 2 2 3 51 , ri^V^V'sv ° I >o -et./ 4 οΑΛΛι7 ^ ' « CH2CH2CH2CNHCH 2' cs2ch3 _ /-“Λ 'o_L o 55
6 H -CHCH2NH-Rg \ o o ra2CH2CH2CNHCH2COEt i.' N—N * . <. J i^T’T‘>· n 0 c' \ 2 5 CH2CH2OCCH3 rr* -CH- tl· 8701226 <6 A * t A Vï *! 1 Η — H *!\—)1 ° -^ ° O \ \ xAlk-C02H xAlk-CONR4R5 \ vA'Y'y, o ®i ^•Alk-C02R3 H C. H O *i \ \ NAlk-C02R3 Alk-C02H ö 7 Γ» 1 9 9 β 0- / V 1 Ia U V Η — Η _, ^/ί'γν Alk-OH Kl X Alk-Rw ** ^00-? ~ *. ? °\ R1 ^ Alk-R R1 XAlk-Rn ±2 £ H Λ °^]—k
2. NaOAc, Ac O 2~;· i + /° i—r1-* A X N/ trap 1 o ®° ' \ R1 Alk-Y O CCH,' H 82ΑΎ”2 rv ^ AA tv AAAA0 trap2 ,ΛΛ/r \ ij. N Alk-Y h Alk-Y 8701226 ·* ·*Ϋ — £ . V-I + ? )°10 —4 CHO «tO)2P Ν Alk-Y Rl μ Η Κ2~3Ρ (1^ γν ^Alk-Y R1 λ «s λ 4 Ο Φ A 8/01 £, £ ο - · ί' 'νΟί-Γτ,/ο'Ή Co;-«;;-ün/ r, *'§ · Γ r^VNV'“\_ II H ‘ /YVv I 2 C1 ^ ir N\ kAA/° x ® R1 «‘s^YVn A I 1 >o r2ak>S/nV Π CH I <j ' λ N | 3 * ^ R aXX)10 ei. T h m ph * ___ y\ N H (AsA>30-CX X>° II \_/ CH, 2
3 Ph 3 lX'V"V'A\ kAA^0 PH (CH.) COZ ^ I 2 n , R, R3 R,-NCO(CH.) 0 Lk-H A/Nyi >^A\n^n/ I I >0 y s4 ^T^V^4· 3 ft7 Λ 19 9 6 W # I £a V Con -
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86681386 | 1986-05-23 | ||
| US06/866,813 US4775674A (en) | 1986-05-23 | 1986-05-23 | Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8701226A true NL8701226A (nl) | 1987-12-16 |
Family
ID=25348473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8701226A NL8701226A (nl) | 1986-05-23 | 1987-05-22 | Imidazochinolinyletherderivaten met geneesmiddelwerking, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten die deze derivaten bevatten. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4775674A (lm) |
| JP (1) | JPS62283972A (lm) |
| KR (1) | KR900008567B1 (lm) |
| AT (1) | AT392790B (lm) |
| AU (1) | AU603577B2 (lm) |
| BE (1) | BE1002033A4 (lm) |
| CA (1) | CA1289137C (lm) |
| CH (1) | CH675246A5 (lm) |
| DE (1) | DE3717291A1 (lm) |
| DK (1) | DK166084C (lm) |
| ES (1) | ES2005588A6 (lm) |
| FI (1) | FI86723C (lm) |
| FR (1) | FR2603586B1 (lm) |
| GB (1) | GB2190676B (lm) |
| GR (1) | GR870803B (lm) |
| HU (1) | HU197570B (lm) |
| IL (1) | IL82612A0 (lm) |
| IT (1) | IT1205031B (lm) |
| LU (1) | LU86896A1 (lm) |
| NL (1) | NL8701226A (lm) |
| NZ (1) | NZ220345A (lm) |
| PT (1) | PT84938B (lm) |
| SE (1) | SE465163B (lm) |
| ZA (1) | ZA873583B (lm) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1306260C (en) * | 1985-10-18 | 1992-08-11 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| JPH01189791A (ja) * | 1988-01-26 | 1989-07-28 | New Japan Radio Co Ltd | 非接触ｉｄカード |
| US4943573A (en) * | 1989-11-01 | 1990-07-24 | Bristol-Myers Squibb Company | Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility |
| US5262540A (en) * | 1989-12-20 | 1993-11-16 | Bristol-Myers Squibb Company | [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters |
| PH31245A (en) * | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
| US5208237A (en) * | 1992-04-03 | 1993-05-04 | Bristol-Meyers Squibb Company | 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
| US5348960A (en) * | 1992-04-03 | 1994-09-20 | Bristol-Myers Squibb Company | Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives |
| US5158958A (en) * | 1992-04-03 | 1992-10-27 | Bristol-Myers Squibb Company | Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives |
| US5187188A (en) * | 1992-04-03 | 1993-02-16 | Bristol-Myers Squibb Company | Oxazole carboxylic acid derivatives |
| US5552267A (en) * | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
| TW593317B (en) | 1993-06-21 | 2004-06-21 | Janssen Pharmaceutica Nv | Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives |
| US6756382B2 (en) * | 1999-06-10 | 2004-06-29 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6541485B1 (en) | 1999-06-10 | 2003-04-01 | 3M Innovative Properties Company | Urea substituted imidazoquinolines |
| US6331539B1 (en) | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| US6573273B1 (en) | 1999-06-10 | 2003-06-03 | 3M Innovative Properties Company | Urea substituted imidazoquinolines |
| JP4767429B2 (ja) * | 2001-03-02 | 2011-09-07 | 株式会社クラレ | 架橋剤および架橋性重合体 |
| WO2004050657A2 (en) * | 2002-11-27 | 2004-06-17 | Artesian Therapeutics, Inc. | COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| WO2005018556A2 (en) | 2003-08-12 | 2005-03-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo-containing compounds |
| ES2406730T3 (es) | 2003-08-27 | 2013-06-07 | 3M Innovative Properties Company | Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi |
| AU2004270201A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| CA2540541C (en) | 2003-10-03 | 2012-03-27 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| EP1685129A4 (en) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
| WO2005048945A2 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| JP4891088B2 (ja) | 2003-11-25 | 2012-03-07 | スリーエム イノベイティブ プロパティズ カンパニー | 置換されたイミダゾ環系および方法 |
| JP2007517035A (ja) | 2003-12-29 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン |
| CA2551399A1 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| CA2559863A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| AU2005326708C1 (en) | 2004-12-30 | 2012-08-30 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| AU2005322898B2 (en) | 2004-12-30 | 2011-11-24 | 3M Innovative Properties Company | Chiral fused (1,2)imidazo(4,5-c) ring compounds |
| CA2597092A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
| WO2006086634A2 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| EP1869043A2 (en) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| CA2602590A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| WO2008008432A2 (en) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| US8227603B2 (en) | 2006-08-01 | 2012-07-24 | Cytokinetics, Inc. | Modulating skeletal muscle |
| US8299248B2 (en) | 2006-08-02 | 2012-10-30 | Cytokinetics, Incorporated | Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use |
| EP2995619B1 (en) | 2006-08-02 | 2019-09-25 | Cytokinetics, Inc. | Certain chemical entities comprising imidazopyrimidines, compositions and methods |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US7851484B2 (en) | 2007-03-30 | 2010-12-14 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| BR112014000742A2 (pt) | 2011-07-13 | 2016-08-23 | Andrew A Wolff | terapia de combinação de als |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| WO2024149378A1 (zh) * | 2023-01-13 | 2024-07-18 | 上海超阳药业有限公司 | 喹啉酮化合物和萘啶酮化合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932407A (en) * | 1973-11-19 | 1976-01-13 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| NL7807507A (nl) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
| IL62402A0 (en) * | 1980-03-24 | 1981-05-20 | Sterling Drug Inc | Imidazo(4,5-b)pyridines,their preparation and pharmaceutical compositions containing them |
| US4490371A (en) * | 1983-02-16 | 1984-12-25 | Syntex (U.S.A.) Inc. | N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides |
| JPS604186A (ja) * | 1983-06-21 | 1985-01-10 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン化合物 |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
| HU193409B (en) * | 1984-02-15 | 1987-10-28 | Syntex Inc | Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides |
| US4668686A (en) * | 1985-04-25 | 1987-05-26 | Bristol-Myers Company | Imidazoquinoline antithrombrogenic cardiotonic agents |
-
1986
- 1986-05-23 US US06/866,813 patent/US4775674A/en not_active Expired - Fee Related
-
1987
- 1987-05-15 AU AU72993/87A patent/AU603577B2/en not_active Ceased
- 1987-05-18 NZ NZ220345A patent/NZ220345A/xx unknown
- 1987-05-19 GB GB8711839A patent/GB2190676B/en not_active Expired - Fee Related
- 1987-05-19 ZA ZA873583A patent/ZA873583B/xx unknown
- 1987-05-20 FI FI872220A patent/FI86723C/fi not_active IP Right Cessation
- 1987-05-21 GR GR870803A patent/GR870803B/el unknown
- 1987-05-21 IL IL82612A patent/IL82612A0/xx not_active IP Right Cessation
- 1987-05-22 DE DE19873717291 patent/DE3717291A1/de not_active Withdrawn
- 1987-05-22 BE BE8700581A patent/BE1002033A4/fr not_active IP Right Cessation
- 1987-05-22 LU LU86896A patent/LU86896A1/fr unknown
- 1987-05-22 JP JP62125642A patent/JPS62283972A/ja active Pending
- 1987-05-22 IT IT20650/87A patent/IT1205031B/it active
- 1987-05-22 FR FR878707252A patent/FR2603586B1/fr not_active Expired - Fee Related
- 1987-05-22 CA CA000537720A patent/CA1289137C/en not_active Expired - Fee Related
- 1987-05-22 AT AT1320/87A patent/AT392790B/de not_active IP Right Cessation
- 1987-05-22 NL NL8701226A patent/NL8701226A/nl not_active Application Discontinuation
- 1987-05-22 KR KR1019870005066A patent/KR900008567B1/ko not_active IP Right Cessation
- 1987-05-22 ES ES8701506A patent/ES2005588A6/es not_active Expired
- 1987-05-22 SE SE8702158A patent/SE465163B/sv not_active IP Right Cessation
- 1987-05-22 HU HU872295A patent/HU197570B/hu not_active IP Right Cessation
- 1987-05-22 DK DK263587A patent/DK166084C/da active
- 1987-05-22 PT PT84938A patent/PT84938B/pt unknown
- 1987-05-25 CH CH2018/87A patent/CH675246A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8701226A (nl) | Imidazochinolinyletherderivaten met geneesmiddelwerking, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten die deze derivaten bevatten. | |
| AT390257B (de) | Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate | |
| US5236940A (en) | Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation | |
| JPH0454671B2 (lm) | ||
| FI93013B (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi | |
| EP1626050B1 (en) | Sulfur-containing naphthoylimide derivatives | |
| DE2740836A1 (de) | Anellierte indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| US6747158B2 (en) | Efficient process for the preparation of a factor Xa inhibitor | |
| EP0329357B1 (en) | Dihydropyridine anti-allergic and anti-inflammatory agents | |
| HU207086B (en) | Process for producing heterocyclic oxophthalazinylacetic acids and pharmaceutical compositions comprising such compounds | |
| US5030646A (en) | Novel tricyclic indole compound | |
| JPS63500518A (ja) | 多環式キノリン、ナフチリジンおよびピラジノピリジン誘導体 | |
| EP0231138B1 (fr) | Dérivés d'acylaminométhyl-1imidazo [1,2-a] quinoléines, leur préparation et leur application en thérapeutique | |
| EP0233800A1 (fr) | Dérivés d'imidazo[1,2-a]quinoléines, leur préparation et leur application en thérapeutique | |
| US3954981A (en) | Triazolocycloalkylhydrothiadiazine derivatives | |
| JPH04502475A (ja) | １，２―ジヒドロ―２―オキソキノキサリンの新規誘導体、その製造および治療への該化合物の適用 | |
| US4356302A (en) | 4H-1,4-Benzothiazine derivatives | |
| PT98285A (pt) | Processo para a preparacao de antagonistas de paf imidazopiridinicos | |
| JPH01203383A (ja) | 抗菌化合物 | |
| EP0568540A1 (en) | 2,4-DIOXO-PYRIDO 2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF | |
| CS221293B2 (en) | Method of making the new derivatives of dihydro-as-triazino/5,6-c/chinoline | |
| NO893611L (no) | Fremstilling av imidazokinolinonderivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BRISTOL-MYERS SQUIBB COMPANY |
|
| BV | The patent application has lapsed |